Equitable Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Equitable Trust’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34,121	Closed	-$1.16M	–	397
2023 Q2	$1.16M	Sell	34,121 -5,119	-13%	-$161K	0.09%	154
2023 Q1	$1.18M	Sell	39,240 -4,887	-11%	-$151K	0.09%	158
2022 Q4	$1.25M	Sell	44,127 -11,639	-21%	-$369K	0.1%	161
2022 Q3	$1.83M	Buy	55,766 +2,971	+6%	+$109K	0.15%	125
2022 Q2	$1.66M	Buy	+52,795	New	+$1.85M	0.12%	141

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Equitable Trust's ARKG Position: Q3 2023 in Review

Equitable Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 34,121 shares — an estimated $1.16M sold.

Equitable Trust first reported a position in ARKG in Q2 2022 and held it in 5 quarters. The position peaked at $1.83M in Q3 2022. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

Equitable Trust reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
Equitable Trust sold 34,121 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $1.16M.
Equitable Trust first reported a position in ARK Genomic Revolution ETF in Q2 2022 and held it in 5 quarters.
Equitable Trust's ARK Genomic Revolution ETF position peaked at $1.83M in Q3 2022.
286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Equitable Trust's 13F filing for Q3 2023, filed 6 Nov 2023.